Welcome to the international HTA database

Showing [21797 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Secukinumab for active and progressive psoriatic arthritis
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Secukinumab for ankylosing spondylitis – second line
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Secukinumab for moderate to severe, active rheumatoid arthritis
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Secukinumab for plaque psoriasis
2021	Scottish Medicines Consortium (SMC)	Secukinumab for the treatment of active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI) evidence in adults who have responded inadequately to nonsteroidal anti-inflammatory drugs (NSAIDs)
2015	NIHR Health Technology Assessment programme	Secukinumab for treating moderate to severe plaque psoriasis
2013	Penn Medicine Center for Evidence-based Practice (CEP)	Securement devices for peripherally inserted central venous catheters (PICCs) and Midline catheters
2018	Penn Medicine Center for Evidence-based Practice (CEP)	Securement of Arterial Catheters
2022	Swiss Federal Office of Public Health (FOPH)	Sedative-hypnotic drugs for the treatment of primary chronic insomnia disorder
2002	University HealthSystem Consortium (UHC)	Sedative/hypnotics
2020	Canary Health Service	Seguridad, efectividad clínica y coste-efectividad de intervenciones para la prevención del delirium en el ingreso hospitalario
2020	Canary Health Service	Seguridad, efectividad y coste-efectividad de los sistemas integrados de infusión subcutánea continua de insulina más sensor de monitorización continua de glucosa
2018	Canary Health Service	Seguridad, efectividad y coste-efectividad del desfibrilador automático implantable subcutáneo en prevención primaria y secundaria de muerte súbita
2013	NIHR Health Technology Assessment programme	SeHCAT (Tauroselcholic [75 selenium] acid) for the investigation of bile acid malabsorption (BAM) and measurement of bile acid pool loss
2022	NIHR Health Technology Assessment programme	SeHCAT (tauroselcholic [75selenium] acid) for the investigation of bile acid diarrhoea in adults: a systematic review and cost-effectiveness analysis
2020	NIHR Health Technology Assessment programme	Seizure first aid training for people with epilepsy attending emergency departments and their significant others: the SAFE intervention and feasibility RCT
2006	HAYES, Inc.	Selected dorsal rhizotomy for cerebral palsy
2000	HAYES, Inc.	Selected dorsal rhizotomy for cerebral palsy
2018	NIHR Health Technology Assessment programme	Selecting pregnant or postpartum women with suspected pulmonary embolism for diagnostic imaging: the DiPEP diagnostic study with decision-analysis modelling
2006	Andalusian Health Technology Assessment Area (AETSA)	Selection and evaluation of patient-targeted Websites in the field of healthcare
1999	Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ)	Selective bowel decontamination before orthotopic liver transplantation - primary research
2008	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Selective cell apheresis in inflammatory bowel disease
2014	NIHR Health Technology Assessment programme	Selective decontamination of the digestive tract in critically ill patients treated in intensive care units: a mixed-methods feasibility study (the SuDDICU study)
2002	Wessex Institute for Health Research and Development (WIHRD)	Selective denervation for spasmodic torticollis
2006	Medical Services Advisory Committee (MSAC)	Selective dorsal rhizotomy (nationally funded centres)
2006	National Institute for Health and Care Excellence (NICE)	Selective dorsal rhizotomy for spasticity in cerebral palsy
2010	National Institute for Health and Care Excellence (NICE)	Selective dorsal rhizotomy for spasticity in cerebral palsy
2011	HAYES, Inc.	Selective Estrogen Receptor Modulators (SERMs) for chemoprevention of breast cancer
1999	NIHR Health Technology Assessment programme	Selective estrogen receptor modulators for osteoporosis
2004	HAYES, Inc.	Selective estrogen receptor modulators for primary breast cancer prevention
2009	HAYES, Inc.	Selective head cooling (Olympic Cool-Cap (Natus Medical Inc.) for treatment of perinatal hypoxic-ischemic encephalopathy (HIE)
2009	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Selective IgG Apheresis for ABO-incompatible kidney transplantation. Systematic Review
2020	NIHR Health Technology Assessment programme	Selective internal radiation therapies for unresectable early-, intermediate- or advanced-stage hepatocellular carcinoma: systematic review, network meta-analysis and economic evaluation
2013	Agenzia nazionale per i servizi sanitari regionali (Agenas)	Selective Internal Radiation Therapy (SIRT) in colorectal liver metastases
2004	National Institute for Clinical Excellence (NICE)	Selective internal radiation therapy for colorectal metastases in the liver
2002	Medical Services Advisory Committee (MSAC)	Selective internal radiation therapy for hepatic metastases using SIR-Spheres(R)
2011	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Selective internal radiation therapy using yttrium-90 microspheres for the treatment of primary or metastatic liver malignancies
2007	HAYES, Inc.	Selective laser trabeculoplasty (SLT) using the Selecta 7000 (Lumenis Inc.) for treatment of primary open-angle glaucoma and ocular hypertension
2008	HAYES, Inc.	Selective pancreatectomy for focal congenital hyperinsulinism (CHI)
2004	National Institute for Clinical Excellence (NICE)	Selective peripheral denervation for cervical dystonia
1997	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Selective serotonin reuptake inhibitors (SSRIs) for major depression. Part 2. The cost-effectiveness of SSRIs in treatment of depression
1997	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Selective serotonin reuptake inhibitors (SSRIs) for major depression. Part I. Evaluation of the clinical literature
2009	HAYES, Inc.	Selective serotonin reuptake inhibitors for the treatment of autism
2010	HAYES, Inc.	Selective serotonin reuptake inhibitors in the treatment of post traumatic stress disorder
1999	Alberta Heritage Foundation for Medical Research (AHFMR)	Selective testing with bone density measurement
2002	NIHR Horizon Scanning Centre (NIHR HSC)	Selective tubal occlusion (Essure) for female sterilisation - horizon scanning review
2001	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Selective tubal occlusion procedure
2006	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Selegiline transdermal patch
2012	HAYES, Inc.	Selenia dimensions digital tomosynthesis system (Hologic Inc.) for diagnostic mammography
1999	Health Council of the Netherlands Gezondheidsraad (GR)	Selenium and its compounds: evaluation of the effects on reproduction, recommendation for classification
2010	NIHR Health Technology Assessment programme	Self monitoring of blood glucose in type 2 diabetes
1999	Agency for Healthcare Research and Quality (AHRQ)	Self-administered drug treatments for acute migraine headache
2018	NIHR Health Technology Assessment programme	Self-care support for children and adolescents with long-term conditions: the REfOCUS evidence synthesis
2014	University of York	Self-care support for people with COPD
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Self-directed cognitive behavioural therapy for adults with diagnosis of depression: systematic review of clinical effectiveness, cost-effectiveness, and guidelines
2006	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Self-expanding metallic stents (SEMS) for relieving malignant colorectal obstruction: a systematic review
2004	National Institute for Clinical Excellence (NICE)	Self-harm: the short-term physical and psychological management and secondary prevention of self-harm in primary and secondary care
2015	Health Quality Ontario (HQO)	Self-management and educational interventions in the postacute stroke population: a rapid review
2018	NIHR Health Technology Assessment programme	Self-Management education for adults with poorly controlled epILEpsy [SMILE (UK)]: a randomised controlled trial
2013	Health Quality Ontario (HQO)	Self-management support interventions for persons with chronic disease: an evidence-based analysis
2017	NIHR Health Technology Assessment programme	Self-management toolkit and delivery strategy for end-of-life pain: the mixed-methods feasibility study
2012	Agency for Healthcare Research and Quality (AHRQ)	Self-measured blood pressure monitoring: comparative effectiveness
2019	Swiss Federal Office of Public Health (FOPH)	Self-measurement of blood glucose in patients with non-insulin treated diabetes mellitus type 2
2006	HAYES, Inc.	Self-monitoring and self-management of oral anticoagulant therapy
2002	HAYES, Inc.	Self-monitoring of oral anticoagulant therapy
2007	The Swedish Council on Health Technology Assessment (SBU)	Self-testing and self-management of oral anticoagulation - early assessment briefs (Alert)
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Selumetinib for KRAS mutation-positive advanced non-small cell lung cancer – second line
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Selumetinib for metastatic uveal melanoma – first line
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Selumetinib with radioactive iodine therapy for differentiated thyroid cancer – first line
2023	Canadian Agency for Drugs and Technologies in Health (CADTH)	Semaglutide 2 mg for type 2 diabetes
2005	HAYES, Inc.	Semi-implantable electromagnetic hearing aids
2002	HAYES, Inc.	Semi-implantable electromagnetic hearing aids
2011	HAYES, Inc.	Semi-implantable electromagnetic hearing aids
2003	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Semi-implantable, middle ear hearing aids
2011	HAYES, Inc.	Sensei X robotic catheter system (Hansen Medical Inc.) for treatment of atrial fibrillation
2013	HAYES, Inc.	SensiGene fetal RHD genotyping
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Sensimed triggerfish® for 24-hour monitoring of changes in intraocular pressure in glaucoma
2009	NIHR Health Technology Assessment programme	Sensitivity analysis in economic evaluation: an audit of NICE current practice and a review of its use and value in decision-making
2014	NIHR Horizon Scanning Centre (NIHR HSC)	SensiumVitals® vital signs monitoring patch
2022	NIHR Health Technology Assessment programme	Sensory integration therapy for children with autism and sensory processing difficulties: the SenITA RCT
2000	HAYES, Inc.	Sensory integration therapy for children with learning disabilities
2004	HAYES, Inc.	Sensory integration therapy for children with learning disabilities or developmental delays
2014	HAYES, Inc.	Sensory integration therapy for non-autistic children
2003	Wessex Institute for Health Research and Development (WIHRD)	Sensory or auditory integration therapy for children with autistic spectrum disorders
2011	HAYES, Inc.	Sensory-based treatments for autism spectrum disorders
2014	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	SentiMag and Sienna+ for sentinel lymph node localisation in breast cancer
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	SentiMag and Sienna+ system for sentinel lymph node biopsy in breast cancer
2012	NIHR Horizon Scanning Centre (NIHR HSC)	SentiMag® and Sienna+® system for sentinel lymph node biopsy in breast cancer
2006	Medical Services Advisory Committee (MSAC)	Sentinel lymph node biopsy in breast cancer
2013	NIHR Health Technology Assessment programme	Sentinel lymph node status in vulval cancer: systematic reviews of test accuracy and decision-analytic model-based economic evaluation
2002	L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES)	Sentinel node biopsy (SNB) in breast cancer - progress report
2000	ECRI	Sentinel node biopsy for staging breast cancer
2001	HAYES, Inc.	Sentinel node biopsy for the staging of breast cancer
2005	HAYES, Inc.	Sentinel node biopsy for the staging of breast cancer
2014	Penn Medicine Center for Evidence-based Practice (CEP)	Separate instrument sets for prevention of tumor seeding during tumor resection and flap surgery
2008	HAYES, Inc.	Seprafilm adhesion barrier (Genzyme Corp.) for nonuterine abdominal adhesions
2012	HAYES, Inc.	Seprafilm adhesion barrier (Genzyme Corp.) for prevention of abdominal adhesions after general abdominal surgery
2012	HAYES, Inc.	Seprafilm adhesion barrier (Genzyme Corp.) for prevention of abdominal adhesions after gynecologic surgery
2008	HAYES, Inc.	Seprafilm adhesion barrier (Genzyme Corp.) for prevention of uterine adhesions
2016	NIHR Health Technology Assessment programme	Sepsis: the LightCycler SeptiFast Test MGRADE®, SepsiTest™ and IRIDICA BAC BSI assay for rapidly identifying bloodstream bacteria and fungi – a systematic review and economic evaluation